Clinical Laserthermia Systems AB (publ) announced that the company's acting CEO Dan J. Mogren returns to work from April 1st, after a planned medical leave from February 10th until March 31st. Dan J. Mogren replaces deputy CEO Lars-Erik Eriksson, who will continue his role as CFO.
Clinical Laserthermia Systems AB
Equities
CLS B
SE0022049920
Advanced Medical Equipment & Technology
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.9 SEK | -1.62% |
|
-2.78% | -78.62% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-78.62% | 4.46M | |
-4.67% | 789M | |
-32.70% | 218M | |
0.00% | 132M | |
-25.07% | 85.86M | |
+0.51% | 53.19M |
- Stock Market
- Equities
- CLS B Stock
- News Clinical Laserthermia Systems AB
- Clinical Laserthermia Systems AB Announces CEO Changes